Anson Funds Management’s CervoMed CRVO Stock Holding History

Anson Funds Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,365	Closed	-$933	–	37
2019 Q2	$933	Buy	+4,365	New	+$1.18M	0.45%	16
2019 Q1	–	Sell	-442	Closed	-$66K	–	35
2018 Q4	$66K	Buy	+442	New	+$151K	0.04%	50

Other funds holding CRVO

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Anson Funds Management's CRVO Position: Q3 2019 in Review

Anson Funds Management sold out of CervoMed (CRVO) in Q3 2019, closing a stake of 4,365 shares — an estimated $933 sold.

Anson Funds Management first reported a position in CRVO in Q4 2018 and held it in 2 quarters. The position peaked at $66K in Q4 2018. 12 funds tracked by Wall St. Rank hold CRVO as of Q3 2019.

Anson Funds Management reported no remaining CervoMed position as of Q3 2019 after selling out during the quarter.
Anson Funds Management sold 4,365 CervoMed shares in Q3 2019, an estimated $933.
Anson Funds Management first reported a position in CervoMed in Q4 2018 and held it in 2 quarters.
Anson Funds Management's CervoMed position peaked at $66K in Q4 2018.
12 funds tracked by Wall St. Rank held CervoMed as of Q3 2019.

Based on Anson Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.